Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia

Accesswire07/22 14:30

Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity

Accesswire07/11 14:40

Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris

Accesswire07/01 13:20

6-K：海外発行者報告書（決算情報）

SEC06/27 01:48

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million

Accesswire06/20 13:20

Biophytis Announces the Successful Industrial Transfer of BIO101 (20-hydroxyecdysone) Production by Its Service Provider Seqens

Accesswire06/12 16:25